Vulval cancer research | Cancer Research UK
Cancer Research UK on Google+ Cancer Research UK on Facebook Cancer Research UK on Twitter

A quick guide to what's on this page

Vulval cancer research

All treatments must be fully researched before they can be adopted as standard treatment for everyone. This is so that we can be sure they work better than the treatments we already use. And so we know that they are safe.

First of all, treatments are developed and tested in laboratories. Only after we know that they are likely to be safe to test are they tested in people, in clinical trials. Cancer Research UK supports a lot of UK laboratory research into cancer and also supports many UK and international clinical trials.

Researchers are looking into


CR PDF Icon You can view and print the quick guides for all the pages in the Treating vulval cancer section.



Why we need research

All treatments have to be fully researched before they can be adopted as standard treatment for everyone. This is so that

  • We can be sure they work
  • We can be sure they work better or have fewer side effects than the treatments that are available at the moment
  • They are known to be safe

First of all, drug treatments are developed and tested in laboratories. For ethical and safety reasons, experimental treatments must be tested in the laboratory before they can be tried in patients. If a treatment described here is said to be at the laboratory stage of research, it is not ready for patients and is not available either within or outside the NHS. Cancer Research UK supports a lot of UK laboratory research into cancer.

Tests in patients are called clinical trials. Cancer Research UK supports many UK and international clinical trials. 

Our trials and research section has information about what trials are including information about the 4 phases of clinical trials. If you are interested in taking part in a clinical trial, click the button on the left of your screen to visit our searchable database of clinical trials recruiting in the UK. If there is a trial you are interested in, print it off and take it to your own specialist. If the trial is suitable for you, your doctor will need to make the referral to the research team. The database also has information about closed trials and trial results.

All the new approaches covered here are the subject of ongoing research. Until studies are completed and new effective treatments are found, these treatments cannot be used as standard therapy for cancer of the vulva.

Here is a video on experiences of taking part in a clinical trial:

View a transcript of the video (Opens in a new window)

Read more about  what trials are. And look at the searchable database of clinical trials.


Checking lymph nodes close to the vulva

If your cancer is stage 1B or greater, your doctor will want to check your lymph nodes near the vulva to see if they contain cancer. Up until recently, the surgeon would remove all of the nearby lymph nodes to check for cancer spread. But this operation has side effects. So doctors are looking for other ways to check lymph nodes close to the vulva, so they do not need to remove lots of them.

One way of checking nearby lymph nodes is called a sentinel lymph node biopsy. The doctor finds the lymph node (or nodes) that cancer cells are most likely to spread to. If this node doesn't contain cancer cells, then the other nodes nearby probably don't either. So if your sentinel node is negative, you don't have to have any other lymph nodes removed. This is valuable because removing all of the lymph nodes in the groin can cause leg swelling called lymphoedema.

Read more about sentinel lymph node biopsy for vulval cancer

This approach is now being used widely for women with vulval cancer. But because it is still a fairly new test in vulval cancer, doctors want to find out more about it. So you may have a sentinel lymph node biopsy as part of a clinical trial 

Read more about trials looking at sentinel node biopsy and vulval cancer, such as the GROINSS-VII study and the PIONIR trial.


Human papilloma virus (HPV)

We know that infection with the human pailloma virus (HPV) is an important risk factor for vulval cancer. Researchers have developed HPV vaccines to stop people becoming infected with HPV. In the future, we hope that the number of women getting vulval cancer will go down, as women have the vaccine and HPV infection is prevented. This will take some years, because vulval cancer takes such a long time to develop.

Read more about HPV vaccines to prevent cancer.

Some  vaccines are being developed that will help your immune system to destroy the virus if you are already infected with it. If you have precancerous vulval cells (VIN), it may be linked to HPV infection. So a vaccine that gets rid of the HPV could stop the VIN from developing. This type of treatment is still very experimental. An early stage UK trial of an antiviral cream combined with an HPV vaccine for women with VIN has shown some responses. And a small Dutch study also found that a HPV vaccine helped some women with VIN. Research is ongoing in this area.

Read more about the UK study looking at immunotherapy for VIN.


Anti viral creams and gels for VIN

VIN (vulval intraepithelial neoplasia) means you have pre cancerous cells in the skin of your vulva. It isn't cancer, but if you have this condition, there is a risk that it might go on to develop into a cancer. VIN is often linked to infection with HPV.

Read more about VIN.

Doctors are looking at new ways to treat this condition. They have looked at creams including

  • Imiquimod
  • Cidofovir

Doctors now use imiquimod to treat some women with VIN.  It works by stimulating the immune system. This means it uses the body's natural defences to kill the HPV. If the HPV is removed, the hope is that the cells affected by VIN will go back to normal. A small Dutch trial and a small UK trial of imiquimod have shown that imiquimod can help about half of the women treated for VIN 2 or 3. But we need to find out whether this response to treatment lasts for a long time.

Read about the UK trial of imiquimod.

Cidofovir cream (or gel) is quite new and still being investigated as a treatment for VIN. A recent study called the RT3 VIN trial found that cidofovir gel and imiquimod were safe treatments and helped women with VIN 3. The researchers recommended that larger trials look at these treatments, and suggested that they could be used instead of surgery. But we still don't know whether these creams work as well as surgery. 

Read about the RT3 VIN trial  

Another cream being looked at by researchers is called Veregen. It contains a substance from green tea. They know that the cream is safe to use and works for women with genital warts. The researchers think it may also help women with VIN 3. The EPIVIN trial is comparing Veregen with a dummy cream (placebo).

Read about the EPIVIN trial.


Photodynamic therapy

Doctors have looked at photodynamic therapy as a treatment for VIN and early vulval cancers. This isn't a routine treatment, but doctors may occasionally use it. We need more research to find out how well it works. For this treatment, you have a chemical injected into a vein that circulates through your body and is absorbed by cancer cells. When the chemical has been taken up by the cells, the doctor shines a bright light on the area of VIN or vulval cancer. The chemical makes the cells very sensitive to light and so the light kills them.

Photodynamic therapy is looking promising. But the treatment is not without its difficulties. If you have a light sensitising drug injected into a vein, all your skin will be at risk of damage just from daylight, until your body has got rid of the drug. So during this time you have to stay in a darkened room, or cover up completely and wear dark glasses if you go out. 


Side effects of radiotherapy

After radiotherapy to the pelvic area, some people can have long term side effects such as bowel problems. For example diarrhoea, a need to rush to the toilet more often than normal or bleeding from the back passage. These side effects happen if the radiotherapy causes a thickening of the tissue in the treatment area, making it less stretchy. This is called radiation fibrosis. Doctors are trying to find ways to relieve the problems caused by this tissue damage.

The HOT II trial looked at whether using a high pressure oxygen treatment called hyberbaric oxygen (HBO) therapy could help relieve the long term side effects of radiotherapy to the area between the hip bones (the pelvis). 84 people took part in the trial. The trial team found no evidence that HBO helped people with bowel side effects from radiotherapy. These results disagree with other reports that say HBO is helpful. So the trial team felt larger trials were needed to know for sure.

The PPALM trial is looking at the use of a palm oil supplement and a drug called pentoxifylline to relieve symptoms caused by pelvic radiotherapy. 

The PREDICT study wants to find out if an electronic nose can predict long term changes in bowel function after pelvic radiotherapy. 

Read more about the HOT II trial, the PPALM trial and the PREDICT study.


Support for women with vulval cancer

Many women have said that getting emotional support when they have gynaecological cancer has helped them to cope. But there is little scientific evidence to back this up. A small study in London looked at how women with gynaecological cancer could be supported by other women who have had similar cancers. Women in one group were contacted by a woman who had had similar treatment, and had special training in giving support. 

Read more about the results of this study.

A small study is looking at rehabilitation for women with gynaecological cancers.  The researchers want to find out whether having 2 planned rehabilitation sessions can help these women return to as normal a life as possible. 

Read more about the study looking at rehabilitation for women with gynaecological cancers.

Rate this page:
Submit rating


Rated 5 out of 5 based on 9 votes
Rate this page
Rate this page for no comments box
Please enter feedback to continue submitting
Send feedback
Question about cancer? Contact our information nurse team

No Error

Updated: 9 January 2014